SCHEMBL24317818

SCHEMBL24317818

CCOC1CCC(N2CC(Oc3cccc(OC)c3)C2)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 1/20 0.50
SLC6A4 P31645 1/20 0.50
SLC6A3 Q01959 1/20 0.50
HRH3 Q9Y5N1 2/20 0.42
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
GRIN1 Q05586 2/20 0.39
GRIN2B Q13224 2/20 0.39
CHRNB4 P30926 1/20 0.39
CHRNA3 P32297 1/20 0.39
PDE3B Q13370 1/20 0.39
PDE3A Q14432 1/20 0.39
PDE10A Q9Y233 1/20 0.39
DRD2 P14416 2/20 0.38
OPRM1 P35372 2/20 0.38
OPRK1 P41145 1/20 0.38
KCNH2 Q12809 1/20 0.38
HTR1A P08908 1/20 0.37
ADRA1D P25100 1/20 0.37
ADRA1A P35348 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26619764 0.88 SLC6A2 (0.54) SLC6A2SLC6A4SLC6A3HRH3MAPT
SCHEMBL24317561 0.86 SLC6A2 (0.49) SLC6A2SLC6A4SLC6A3HRH3KCNH2
SCHEMBL27010171 0.83 SLC6A2 (0.49) SLC6A2SLC6A4SLC6A3HRH3MAPT
SCHEMBL13798741 0.76 SLC6A2 (0.67) SLC6A2SLC6A4SLC6A3CHRNB4CHRNA3
SCHEMBL26619758 0.75 SLC6A2 (0.52) SLC6A2SLC6A4SLC6A3HRH3MAPT
SCHEMBL26619696 0.75 SLC6A2 (0.51) SLC6A2SLC6A4SLC6A3HRH3KCNH2
SCHEMBL7533532 0.74 SLC6A2 (0.45) SLC6A2SLC6A4SLC6A3HRH3MAPT
SCHEMBL7533925 0.74 SLC6A2 (0.45) SLC6A2SLC6A4SLC6A3HRH3MAPT
SCHEMBL7533530 0.74 SLC6A2 (0.45) SLC6A2SLC6A4SLC6A3HRH3MAPT
SCHEMBL26632862 0.73 SLC6A2 (0.50) SLC6A2SLC6A4SLC6A3HRH3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081927-A1 TRICYCLIC COMPOUNDS TO DEGRADE NEOSUBSTRATES FOR MEDICAL THERAPY C4 THERAPEUTICS, INC. (US) 2022-04-21 WO disclosed